Organization Overview
Historical Acquisition Tree
Alternative names
Key: Thermo Fisher Scientific (1) Acquired (12)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ada) cdna sequence from human haematopoietic stem/progenitor (cd34+) cells (1 trial)
Key: Thermo Fisher Scientific (1) Acquired (87)
abiraterone (zytiga) (1 trial)
adenosine (Adenocard) (2 trials)
albiglutide (tanzeum) (2 trials)
amlodipine (norvasc) (1 trial)
atazanavir (reyataz) (2 trials)
atorvastatin (lipitor) (5 trials)
benralizumab (fasenra) (1 trial)
bifidobacterium bifidum (1 trial)
brinzolamide (azopt) (1 trial)
carboplatin (paraplatin) (1 trial)
celecoxib (celebrex) (1 trial)
certolizumab pegol (cimzia) (3 trials)
cisplatin (platinol) (2 trials)
docetaxel (taxotere) (2 trials)
docosahexaenoic acid (4 trials)
dolutegravir (tivicay) (4 trials)
dorzolamide (trusopt) (1 trial)
emtricitabine (emtriva) (1 trial)
eprosartan (teveten) (1 trial)
fingolimod (gilenya) (1 trial)
fospropofol (lusedra) (6 trials)
gemcitabine (gemzar) (3 trials)
indinavir (crixivan) (1 trial)
influenza vaccine, recombinant hemagglutinin (1 trial)
insulin glargine (toujeo) (1 trial)
ketoprofen (orudis) (5 trials)
lactobacillus delbrueckii (1 trial)
lamivudine (epivir) (3 trials)
lansoprazole (prevacid) (1 trial)
levofloxacin (levaquin) (1 trial)
lidocaine (xylocaine) (2 trials)
mepolizumab (Nucala) (1 trial)
necitumumab (portrazza) (2 trials)
renal autologous cell therapy (1 trial)
reslizumab (cinqair) (1 trial)
s-adenosyl methionine (1 trial)
sodium selenium oxide (1 trial)
tacrolimus (prograf) (2 trials)
testosterone (delatestryl) (1 trial)
tetracaine (pontocaine) (1 trial)
travoprost (travatan) (1 trial)
treprostinil (remodulin) (9 trials)
vinorelbine (navelbine) (1 trial)
Key: Thermo Fisher Scientific (3) Acquired (90)
albuterol (proventil) (1 trial)
allogeneic adipose derived mesenchymal stem cell (3 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
asfotase alfa (strensiq) (1 trial)
aspergillus niger prolyl endoprotease (1 trial)
basiliximab (simulect) (1 trial)
belatacept (nujolix) (2 trials)
binimetinib (mektovi) (1 trial)
bupropion (wellbutrin) (1 trial)
carfilzomib (kyprolis) (1 trial)
daratumumab (darzalex) (1 trial)
dasatinib (sprycel) (2 trials)
decitabine (dacogen) (1 trial)
dupilumab (dupixent) (1 trial)
encorafenib (braftovi) (1 trial)
enoxaparin (lovenox) (1 trial)
fenofibrate (fenoglide) (2 trials)
fish oil (Omegavan) (2 trials)
fluticasone (cutivate) (1 trial)
heat-labile enterotoxin of e. coli (2 trials)
interferon alpha-2b (Intron-A) (2 trials)
Lactobacillus acidophilus (1 trial)
lenalidomide (revlimid) (1 trial)
lomitapide (juxtapid) (2 trials)
methylprednisolone (medrol) (1 trial)
mycophenolate (myfortic) (1 trial)
omega-3-carboxylic acids (epanova) (1 trial)
omega-3 fatty acids (omacor) (1 trial)
pembrolizumab (keytruda) (2 trials)
Key: Thermo Fisher Scientific (8) Acquired (64)
cat epidermis allergen (2 trials)
cobicistat (stribild) (1 trial)
crizotinib (xalkori) (1 trial)
droxidopa (northera) (1 trial)
escitalopram (lexapro) (1 trial)
esomeprazole (nexium) (1 trial)
flurbiprofen (ansaid) (1 trial)
granisetron (kytril) (1 trial)
house dust mite allergen (2 trials)
live attenuated influenza virus vaccine (flumist) (1 trial)
montelukast (singulair) (2 trials)
moxifloxacin (avelox) (2 trials)
n-methylnicotinamide chloride (1 trial)
olanzapine (zyprexa) (1 trial)
ombitasvir (Viekira Pak) (1 trial)
omeprazole (prilosec) (2 trials)
pravastatin (pravachol) (1 trial)
Key: Thermo Fisher Scientific (1) Acquired (36)
5-methyl-tetrahydrofolate (1 trial)
belimumab (benlysta) (1 trial)
chromium tripicolinate (1 trial)
erwinia asparaginase (Erwinaze) (1 trial)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Diabetes Insipidus (Phase 3)
Diabetes Mellitus (Phase 2)
Food Hypersensitivity (Phase 4)
Heart Failure (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)